Record Information |
---|
Version | 2.0 |
---|
Created at | 2006-05-22 14:17:33 UTC |
---|
Updated at | 2021-10-07 20:42:22 UTC |
---|
NP-MRD ID | NP0000769 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | 2-Pyrrolidinone |
---|
Description | 2-Pyrrolidinone is a lactam cyclization product of gamma-aminobutyric acid (GABA) (PMID 10332870 ). Vigabatrin (VGB, an antiepileptic drug) increases human brain gamma-aminobutyric acid (GABA) and the related metabolites, including 2-pyrrolidinone. Patients taking VGB are expected to have an increase of these metabolites (PMID 10403220 , 10840398 ). 2-Pyrrolidone is an organic compound consisting of a five-membered lactam. It is a colorless liquid which is used in industrial settings as a high-boiling non-corrosive polar solvent for a wide variety of applications. It is miscible with a wide variety of other solvents including water, ethanol, diethyl ether, chloroform, benzene, ethyl acetate and carbon disulfide. |
---|
Structure | InChI=1S/C4H7NO/c6-4-2-1-3-5-4/h1-3H2,(H,5,6) |
---|
Synonyms | Value | Source |
---|
1-Azacyclopentan-2-one | ChEBI | 2-Ketopyrrolidine | ChEBI | 2-Oxopyrrolidine | ChEBI | 2-Pyrrolidone | ChEBI | 4-Aminobutyric acid lactam | ChEBI | alpha-Pyrrolidinone | ChEBI | alpha-Pyrrolidone | ChEBI | Butyrolactam | ChEBI | gamma-Aminobutyric acid lactam | ChEBI | gamma-Aminobutyric lactam | ChEBI | gamma-Butyrolactam | ChEBI | Pyrrolidinone | ChEBI | Pyrrolidone | ChEBI | 4-Aminobutyrate lactam | Generator | a-Pyrrolidinone | Generator | Α-pyrrolidinone | Generator | a-Pyrrolidone | Generator | Α-pyrrolidone | Generator | g-Aminobutyrate lactam | Generator | g-Aminobutyric acid lactam | Generator | gamma-Aminobutyrate lactam | Generator | Γ-aminobutyrate lactam | Generator | Γ-aminobutyric acid lactam | Generator | g-Aminobutyric lactam | Generator | Γ-aminobutyric lactam | Generator | g-Butyrolactam | Generator | Γ-butyrolactam | Generator | 2-Pyrrolidone, hydrotribromide | HMDB | 2-Pyrrolidone, rubidium salt | HMDB | 2-Pyrrolidone, (18)O-labeled | HMDB | 2-Pyrrolidone, 5-(14)C-labeled | HMDB | 2-Pyrrolidone, potassium salt | HMDB | 2-Pyrrolidone, sodium salt | HMDB | 2-Pyrrolidone, aluminum salt | HMDB | 2-Pyrrolidone, cerium salt | HMDB | 2-Pyrrolidone, hydrobromide | HMDB | 2-Pyrrolidone, hydrochloride | HMDB | 2-Pyrrolidone, lithium salt | HMDB | 1-Methyl-2-pyrrolidinone | HMDB | 2-Pyrol4-aminobutyric acid lactam | HMDB | 2-Pyrrolidone for synthesis | HMDB | 2-Pyrrolidone-butyrolactam | HMDB | Aminobutyric acid lactam | HMDB | Aminobutyric lactam | HMDB | Aminobutyrolactam | HMDB | N-Methyl-2-pyrrolidinone | HMDB | Pyrrolidin-2-one | HMDB | Pyrrolidon | HMDB | Pyrrolidone-2 | HMDB | Tetrahydropyrrolone | HMDB | 2-Pyrrolidinone | ChEBI |
|
---|
Chemical Formula | C4H7NO |
---|
Average Mass | 85.1045 Da |
---|
Monoisotopic Mass | 85.05276 Da |
---|
IUPAC Name | pyrrolidin-2-one |
---|
Traditional Name | pyrrolidone |
---|
CAS Registry Number | 616-45-5 |
---|
SMILES | O=C1CCCN1 |
---|
InChI Identifier | InChI=1S/C4H7NO/c6-4-2-1-3-5-4/h1-3H2,(H,5,6) |
---|
InChI Key | HNJBEVLQSNELDL-UHFFFAOYSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 1H NMR Spectrum (1D, 500 MHz, CDCl3, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Species Where Detected | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as pyrrolidine-2-ones. These are pyrrolidines which bear a C=O group at position 2 of the pyrrolidine ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Pyrrolidines |
---|
Sub Class | Pyrrolidones |
---|
Direct Parent | Pyrrolidine-2-ones |
---|
Alternative Parents | |
---|
Substituents | - 2-pyrrolidone
- Secondary carboxylic acid amide
- Lactam
- Carboxamide group
- Azacycle
- Carboxylic acid derivative
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Carbonyl group
- Aliphatic heteromonocyclic compound
|
---|
Molecular Framework | Aliphatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | 23 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 1000 mg/mL at 20 °C | Not Available | LogP | -0.85 | Sasaki, H., Mori, Y., Nakamura, J., & Shibasaki, J. (1991). Synthesis and anticonvulsant activity of 1-acyl-2-pyrrolidinone derivatives. Journal of medicinal chemistry, 34(2), 628-633. |
|
---|
Predicted Properties | |
---|
General References | - Petroff OA, Hyder F, Mattson RH, Rothman DL: Topiramate increases brain GABA, homocarnosine, and pyrrolidinone in patients with epilepsy. Neurology. 1999 Feb;52(3):473-8. [PubMed:10025774 ]
- Sun X, Qiao H, Jiang H, Zhi X, Liu F, Wang J, Liu M, Dong D, Kanwar JR, Xu R, Krissansen GW: Intramuscular delivery of antiangiogenic genes suppresses secondary metastases after removal of primary tumors. Cancer Gene Ther. 2005 Jan;12(1):35-45. [PubMed:15486558 ]
- Hyder F, Petroff OA, Mattson RH, Rothman DL: Localized 1H NMR measurements of 2-pyrrolidinone in human brain in vivo. Magn Reson Med. 1999 May;41(5):889-96. [PubMed:10332870 ]
- Rambabu K, Pattabiraman TN: Studies on gamma-glutamyl transpeptidase of human urine. Clin Chim Acta. 1976 Dec 1;73(2):251-5. [PubMed:11907 ]
- Matsudo T, Ogawa K, Kokufuta E: Complex formation of protein with different water-soluble synthetic polymers. Biomacromolecules. 2003 Nov-Dec;4(6):1794-9. [PubMed:14606910 ]
- Fedi AM, Leoncini P, Farella V, Lotti T: [Study of filaggrin in psoriasis]. G Ital Dermatol Venereol. 1989 Apr;124(4):141-5. [PubMed:2680915 ]
- Gobbels M, Spitznas M: Effects of artificial tears on corneal epithelial permeability in dry eyes. Graefes Arch Clin Exp Ophthalmol. 1991;229(4):345-9. [PubMed:1916322 ]
- Gobbels M, Spitznas M: Corneal epithelial permeability of dry eyes before and after treatment with artificial tears. Ophthalmology. 1992 Jun;99(6):873-8. [PubMed:1630776 ]
- Onorato JM, Henion JD, Lefebvre PM, Kiplinger JP: Selected reaction monitoring LC-MS determination of idoxifene and its pyrrolidinone metabolite in human plasma using robotic high-throughput, sequential sample injection. Anal Chem. 2001 Jan 1;73(1):119-25. [PubMed:11195494 ]
- Zimmermann W, Donhardt A, Braun W: [2-Br-2-ethyl-4-hydroxybutyramide and 2-Br-2-ethyl-4-butyrolactam as carbromal metabolites (author's transl)]. Arch Toxicol. 1978 Apr 27;40(2):119-24. [PubMed:26319 ]
- Voigt R, Korner I, Roth P: [Interactions between macromolecular adjuvants and drugs. Part 16: Effects of human serum albumin and Mg2+ on oxytetracycline-polyvinylpyrrolidone interactions (author's transl)]. Pharmazie. 1979 Jan;34(1):45-8. [PubMed:432255 ]
- Petroff OA, Hyder F, Collins T, Mattson RH, Rothman DL: Acute effects of vigabatrin on brain GABA and homocarnosine in patients with complex partial seizures. Epilepsia. 1999 Jul;40(7):958-64. [PubMed:10403220 ]
- Petroff OA, Hyder F, Rothman DL, Mattson RH: Effects of gabapentin on brain GABA, homocarnosine, and pyrrolidinone in epilepsy patients. Epilepsia. 2000 Jun;41(6):675-80. [PubMed:10840398 ]
|
---|